Abstract Recombinant adenovirus (rAd) regimens. including replication-competent oncolytic adenovirus (OAV) and replication-deficient adenovirus. have been identified as potential cancer therapeutics. OAV presents advantages such as selective replication. https://emporiumsmokeshopstles.shop/product-category/bats/